Formulary Monographs [GLARGINE, 682008]
|
|
GLARGINE
|
|
|
|
|
|
INSULINS
|
|
|
Diabetes mellitus. For use in patients with Type I Diabetes.
|
|
|
Local reactions, fat hypertrophy at injection site. Insulin glargine
preparations are not bioequivalent ; dose adjustment and close metabolic monitoring is recommended if switching between preparations. |
|
|
Once daily at the same time each day.
|
|
|
|
|
|
|
|
|
|
|
|
|